propranolol has been researched along with molsidomine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (47.83) | 18.7374 |
| 1990's | 8 (34.78) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanc, F; Bruel, JM; Ciurana, AJ; Le Quellec, A; Michel, H; Monnin, JL; Pascal, JP; Taourel, P; Vinel, JP | 1 |
| Lebrec, D | 1 |
| Chumburidze, VB; Kipshidze, NN | 1 |
| Borisov, AV | 1 |
| Beaufils, P; Bory, M; Bourdarias, JP; Gilgenkrantz, JM; Guize, L; Kolsky, H; Letac, B; Nicolas, G; Sellier, P; Witchitz, S | 1 |
| Vakaliuk, IP | 1 |
| Amaro Cendón, A; Gil de la Peña, M; González Juanatey, JR; Rubio Alvarez, J | 1 |
| Brockmeier, D; Ostrowski, J | 1 |
| Bichko, MV; Korabel'shchikova, NI; Rishko, NV | 2 |
| Furkalo, NK; Ivashchenko, TI; Romanenko, AI | 1 |
| Balakumaran, K; Chadha, DR; Hugenholtz, PG; Tijssen, JG | 1 |
| Balnave, K; Russell, C; Shanks, RG | 1 |
| Ellis, JL; Fernandes, LB; Undem, BJ | 1 |
| Badia, P; Barange, K; Combis, F; Combis, JM; Desmorat, H; Pascal, JP; Payen, JL; Vinel, JP | 1 |
| Bandi, JC; Bosch, J; Casado, M; Escorsell, A; Feu, F; García-Pagán, JC; Moitinho, E; Rodés, J | 1 |
| Ebihara, Y; Karmazyn, M | 1 |
| Hori, N; Kashima, K; Mori, T; Okanoue, T; Sawa, Y | 1 |
| Casadei, B; Hogan, N; Paterson, DJ | 1 |
| Lee, S; Rivier, C; Seo, DO | 1 |
| Mak, IT; Weglicki, WB | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 review(s) available for propranolol and molsidomine
| Article | Year |
|---|---|
Current status and future goals of the pharmacologic reduction of portal hypertension.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Hemodynamics; Humans; Hypertension, Portal; Molsidomine; Propranolol; Receptors, Serotonin | 1990 |
6 trial(s) available for propranolol and molsidomine
| Article | Year |
|---|---|
[Evaluation of the effects of molsidomine and propranolol-molsidomine combination on portal hemodynamics by pulsed Doppler ultrasound].
Topics: Adult; Aged; Blood Flow Velocity; Drug Therapy, Combination; Female; Humans; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Molsidomine; Portal Vein; Propranolol; Reference Values; Ultrasonics; Ultrasonography | 1992 |
[Treatment of unstable angina. A randomized double-blind study of propranolol, diltiazem and molsidomine].
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Female; Humans; Male; Middle Aged; Molsidomine; Propranolol | 1986 |
[Rheological properties of blood in patients with stenocardia during treatment with obsidan, corvatone and corinfar].
Topics: Adult; Angina Pectoris; Blood Viscosity; Clinical Trials as Topic; Humans; Male; Middle Aged; Molsidomine; Nifedipine; Oxadiazoles; Propranolol; Sydnones; Vasodilator Agents | 1985 |
Molsidomine, an effective long-acting anti-anginal drug.
Topics: Angina Pectoris; Clinical Trials as Topic; Headache; Heart Ventricles; Humans; Male; Molsidomine; Nitroglycerin; Oxadiazoles; Physical Exertion; Propranolol; Sydnones; Time Factors | 1983 |
The effects of cyclosidimine, a peripheral vasodilator drug, on blood pressure and heart rate in healthy subjects.
Topics: Adult; Blood Pressure; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Molsidomine; Morpholines; Posture; Propranolol; Vasodilator Agents | 1984 |
Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Middle Aged; Molsidomine; Portal System; Propranolol; Splanchnic Circulation; Time Factors | 1996 |
16 other study(ies) available for propranolol and molsidomine
| Article | Year |
|---|---|
[Various aspects of drug therapy of chronic forms of ischemic heart disease].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Angina Pectoris; Calcium Channel Blockers; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Molsidomine; Nitroglycerin; Oxyfedrine; Propranolol; Sydnones; Vasodilator Agents | 1985 |
[Effectiveness of combined administration of obsidan and sidnofarm in patients with ischemic heart disease at a polyclinic].
Topics: Adult; Aged; Ambulatory Care; Angina Pectoris; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Molsidomine; Propranolol; Vasodilator Agents | 1988 |
[Biorhythm influence on the course of ischemic heart disease during combined treatment with molsidomine and anaprilin].
Topics: Angina Pectoris; Coronary Disease; Drug Therapy, Combination; Emergencies; Humans; Molsidomine; Periodicity; Physical Exertion; Propranolol | 1986 |
[Molsidomin in stable stress angina].
Topics: Angina Pectoris; Exercise Test; Humans; Molsidomine; Oxadiazoles; Propranolol; Sydnones | 1985 |
Mean time and first-pass metabolism.
Topics: Humans; Models, Biological; Molsidomine; Nortriptyline; Pharmaceutical Preparations; Propranolol; Regression Analysis; Sydnones; Time Factors | 1985 |
[Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].
Topics: Adult; Angina Pectoris; Drug Evaluation; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Molsidomine; Nifedipine; Oxadiazoles; Propranolol; Spirometry; Sydnones; Vasodilator Agents | 1985 |
[Relation between therapeutic efficacy of antianginal preparations in patients with ischemic heart disease and their effect on the rheologic properties of blood].
Topics: Adult; Amiodarone; Benzofurans; Blood Coagulation; Blood Viscosity; Coronary Disease; Erythrocyte Aggregation; Humans; Isosorbide Dinitrate; Male; Middle Aged; Molsidomine; Nitroglycerin; Oxadiazoles; Platelet Adhesiveness; Platelet Aggregation; Propranolol; Sydnones; Vasodilator Agents | 1985 |
Potentiation of nonadrenergic noncholinergic relaxation of human isolated bronchus by selective inhibitors of phosphodiesterase isozymes.
Topics: Atropine; Bronchi; Colforsin; Electric Stimulation; Histamine; Humans; In Vitro Techniques; Indomethacin; Isoenzymes; Molsidomine; Muscle Relaxation; Nitroprusside; Phosphodiesterase Inhibitors; Propranolol; Purinones; Pyrrolidinones; Rolipram | 1994 |
Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
Topics: Adrenergic beta-Antagonists; Drug Synergism; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Molsidomine; Propranolol; Vasodilator Agents; Venous Pressure | 1996 |
Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Calcium; Cell Size; Cells, Cultured; Cyclic GMP; Isoproterenol; Male; Molsidomine; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Penicillamine; Perfusion; Phenylephrine; Propranolol; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Stimulation, Chemical; Vasodilator Agents | 1996 |
Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
Topics: Animals; Drug Therapy, Combination; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Molsidomine; Propranolol; Rats; Rats, Wistar; Splanchnic Circulation; Vascular Resistance; Vasodilator Agents | 1996 |
Nitric oxide donors can increase heart rate independent of autonomic activation.
Topics: Adrenergic beta-Antagonists; Animals; Autonomic Nervous System; Baroreflex; Cardiovascular Agents; Heart Rate; In Vitro Techniques; Male; Molsidomine; Nitric Oxide Donors; Nitroprusside; Propranolol; Pyrimidines; Rabbits; Sympathectomy; Vagotomy; Vasodilator Agents | 1999 |
Role of specific adrenergic receptors in mediating the adrenocorticotropic hormone response to increased nitric oxide levels.
Topics: Adrenal Glands; Adrenergic Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Animals; Clonidine; Dobutamine; Hypothalamus; Injections, Intraventricular; Male; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Norepinephrine; Phenylephrine; Pituitary Gland; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic | 2003 |
Potent antioxidant properties of 4-hydroxyl-propranolol.
Topics: Animals; Antioxidants; Cell Survival; Cells, Cultured; Drug Interactions; Endothelial Cells; Glutathione; Humans; Hydroxyl Radical; Lipoproteins, LDL; Male; Molsidomine; Oxidation-Reduction; Propranolol; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |